(Q45209475)
English
A pharmacogenetic effect of factor XIII valine 34 leucine polymorphism on fibrinolytic therapy for acute myocardial infarction.
scientific article published in January 2005
- A pharmacogenetic effect of factor XIII valine 34 leucine polymorphism on fibrinolytic therapy for acute myocardial infarction
Statements
A pharmacogenetic effect of factor XIII valine 34 leucine polymorphism on fibrinolytic therapy for acute myocardial infarction (English)
Gregory Y H Lip
Francisco Marín
Rocío González-Conejero
Kaeng W Lee
Francisca López